Newsfeeds - Spark Newswire

1 minute read

Clarivate Is In Early Stages Of Turnaround, BofA Says

Today, 10:56 PM

Clarivate Plc’s (NYSE: CLVT) turnaround strategies are likely to lead to accelerated growth and more consistent performance, according to BofA Securities. The Clarivate Analyst: David Chu initiated coverage of Clarivate with a Buy rating and $28 price target.

CLVT

1 minute read

Clarivate Acquires Bioinfogate For Undisclosed Terms To Expand Drug R&D Intelligence

By Anusuya Lahiri

Today, 10:56 PM

Clarivate PLC (NYSE:CLVT) acquired Bioinfogate, an analytics solutions provider in the life sciences and producer of the OFF-X portal. The financial…

CLVT

1 minute read

Clarivate Stock Falls After In-line Q2 Earnings, Trimmed FY21 EPS Outlook

By Akanksha

Today, 10:56 PM

Clarivate PLC (NYSE:CLVT) reported second-quarter revenue growth of 61.4% year-over-year to $447 million (up 5% on an organic basis), beating the…

CLVT

22 minute read

Earnings Scheduled For July 29, 2021

By Benzinga Insights

Today, 10:56 PM

Companies Reporting Before The Bell • Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter.

4 minute read

Options

10 Industrials Stocks With Unusual Options Alerts In Today’s Session

By Benzinga Insights

Today, 10:56 PM

This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Unusual trading activity could push option prices to hyperbolic or underperforming levels.

AAL

3 minute read

One In Five Russell 3000 Additions Went Public Via SPAC: What Investors Should Know

By Chris Katje

Today, 10:56 PM

One of the biggest events for investors last week was the new additions to the Russell 3000 Index. The inclusion in the index means several ETFs have to add shares of the stocks as part of the rebalancing efforts.

AEVA

Latest news

Clarivate Is In Early Stages Of Turnaround, BofA Says

Clarivate Acquires Bioinfogate For Undisclosed Terms To Expand Drug R&D Intelligence

Clarivate Stock Falls After In-line Q2 Earnings, Trimmed FY21 EPS Outlook

Earnings Scheduled For July 29, 2021

10 Industrials Stocks With Unusual Options Alerts In Today’s Session

One In Five Russell 3000 Additions Went Public Via SPAC: What Investors Should Know